TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from ImExHS Limited ( (AU:IME) ) is now available.
IMEXHS Limited reported a slight decrease in revenues by 0.9% to $13.66 million for the half-year ending June 2025, alongside a significant increase in losses by 97.9% to $3 million. No dividends were declared during this period, and the financial statements received an unmodified opinion with an emphasis on going concern, highlighting challenges in the company’s financial performance.
The most recent analyst rating on (AU:IME) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on ImExHS Limited stock, see the AU:IME Stock Forecast page.
More about ImExHS Limited
IMEXHS Limited operates in the medical imaging technology industry, providing advanced imaging solutions and services. The company focuses on delivering innovative products to healthcare providers, enhancing diagnostic capabilities and patient care.
Average Trading Volume: 32,732
Technical Sentiment Signal: Sell
Current Market Cap: A$12.07M
Learn more about IME stock on TipRanks’ Stock Analysis page.